| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308842A1 Pharmaceutical compositions |
| 04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2011 | EP2308486A1 Pufa supplements |
| 04/13/2011 | EP2308484A1 Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
| 04/13/2011 | EP2307549A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 04/13/2011 | EP2307418A1 Novel phenylimidazopyrazines |
| 04/13/2011 | EP2307382A1 Aminotetrahydroindazoloacetic acids |
| 04/13/2011 | EP2307378A1 Nicotinamide derivatives |
| 04/13/2011 | EP2307377A1 Nicotinamide derivatives |
| 04/13/2011 | EP2307362A2 Antagonists of prostaglandin d2 receptors |
| 04/13/2011 | EP2307040A1 Method and means for treating viral disease, in particular hiv/aids |
| 04/13/2011 | EP2306994A1 S1p1 receptor agonists and use thereof |
| 04/13/2011 | EP2188252B1 1-(4-(4-benzylbenzamido)-benzyl)azetidine-3-carboxylic acid derivatives and related compounds as s1p receptor modulators for the treatment of immune disorders |
| 04/13/2011 | EP1542978B1 Novel bio-active molecules |
| 04/13/2011 | EP1539783B1 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 04/13/2011 | EP1539763B1 Azaindole kinase inhibitors |
| 04/13/2011 | CN1939296B Theapolyphenol composition and its preparation |
| 04/13/2011 | CN1763097B Polypeptide variants with altered effector function |
| 04/13/2011 | CN1625400B 2,4-pyrimidinediamine compounds and their uses |
| 04/13/2011 | CN102015763A Affinity matured CRIg variants |
| 04/13/2011 | CN102015757A Modified Cpn10 and PRR signalling |
| 04/13/2011 | CN102015750A 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use |
| 04/13/2011 | CN102015695A Pyridin-2-yl derivatives as immunomodulating agents |
| 04/13/2011 | CN102015678A Fused pyridines active as inhibitors of c-Met |
| 04/13/2011 | CN102015656A Phenylpropionic acid derivative and use thereof |
| 04/13/2011 | CN102015651A Compounds and compositions as TLR activity modulators |
| 04/13/2011 | CN102015644A Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 04/13/2011 | CN102014941A Activation of innate and adaptive immune responses by a ginseng extract |
| 04/13/2011 | CN102014937A Allogeneic cancer cell-based immunotherapy |
| 04/13/2011 | CN102014933A Use of deuterium oxide as an elastase inhibitor |
| 04/13/2011 | CN102014889A Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components |
| 04/13/2011 | CN102014673A Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings |
| 04/13/2011 | CN102010471A Interleukin-10 antibodies |
| 04/13/2011 | CN102010460A Tea seed polypeptide and preparation method thereof |
| 04/13/2011 | CN102010324A Aspirin-triggered lipid mediators |
| 04/13/2011 | CN102010298A Indene derivatives as pharmaceutical agents |
| 04/13/2011 | CN102008732A Folate conjugated antibody medicament and preparation method and application thereof |
| 04/13/2011 | CN102008713A Ciclosporin A proliposome, pharmaceutical composition and preparation method thereof |
| 04/13/2011 | CN102008705A Medicinal and edible dual-purpose ginger-date ying-wei particle used for cold at early stage |
| 04/13/2011 | CN102008654A Method for manufacturing dendrobium officinale fresh juice stock solution |
| 04/13/2011 | CN102008642A Traditional Chinese medicine for treating lupus erythematosus and inhibiting glucocorticoid side effect and application of traditional Chinese medicine |
| 04/13/2011 | CN102008640A Oral preparation capable of tonifying qi and building body and preparation method thereof |
| 04/13/2011 | CN102008581A Improved infant immunity decoction |
| 04/13/2011 | CN102008541A Method for simultaneously detecting three main active ingredients in sugar-free type compound wintercreeper preparation |
| 04/13/2011 | CN102008515A Construction method of ganoderma spore powder polysaccharide fingerprint and standard fingerprint of ganoderma spore powder polysaccharide |
| 04/13/2011 | CN102008503A Hematopoietic cells from human embryonic stem cells |
| 04/13/2011 | CN102008494A 20(R)-ginsenoside Rg3 medicinal water-solubility intermediate, freeze-dried powder injection and preparation method thereof |
| 04/13/2011 | CN102008489A Liquid multi-dimensional formula, and preparation process and application thereof |
| 04/13/2011 | CN102008474A Application of nitidine chloride to preparation of medicament for resisting autoimmunity disease and graft versus host disease |
| 04/13/2011 | CN102008468A Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases |
| 04/13/2011 | CN102008460A Anti-allergic agent |
| 04/13/2011 | CN102008429A Tacrolimus controlled release preparation and preparation method thereof |
| 04/13/2011 | CN101664497B Pharmaceutical composition for treating pediatric dermatosis |
| 04/13/2011 | CN101485741B Paste for treating allergic purpura and chilblain |
| 04/13/2011 | CN101380340B Wall-broken glossy ganoderma spore powder antioxidation method |
| 04/13/2011 | CN101115709B Aminocarboxylic acid derivative and medicinal use thereof |
| 04/12/2011 | US7923559 7-(3-pyridyl)-1,7-diazaspiro[4.4]nonane; mania, anxiety, dyslexia, schizophrenia, depression, obsessive-compulsive disorders, Tourette's syndrome |
| 04/12/2011 | US7923535 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins |
| 04/12/2011 | US7923461 TNF-α production inhibitors |
| 04/12/2011 | US7923436 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/12/2011 | US7923430 Methods for producing modified glycoproteins |
| 04/12/2011 | US7923247 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
| 04/12/2011 | US7923209 Allergen peptide fragments and use thereof |
| 04/12/2011 | US7923017 Modified Vaccinia Ankara virus variant |
| 04/12/2011 | CA2626498C Recombinant chimeric virus |
| 04/12/2011 | CA2488775C Fcyriia transgenic animal model for autoimmune disease |
| 04/12/2011 | CA2475619C Piperidine derivatives |
| 04/12/2011 | CA2388363C Dna polymerase lambda and uses thereof |
| 04/12/2011 | CA2354153C Compounds and methods for modulating activation of nf-.kappa.b |
| 04/12/2011 | CA2277365C Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| 04/07/2011 | WO2011041634A1 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| 04/07/2011 | WO2011040651A1 Therapeutic agent for atopic dermatitis |
| 04/07/2011 | WO2011040535A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | WO2011040071A1 Antioxidant composition |
| 04/07/2011 | WO2011040070A1 Oral composition for alleviation of ultraviolet radiation-induced damage |
| 04/07/2011 | WO2011040052A1 Therapeutic agent for atopic dermatitis |
| 04/07/2011 | WO2011039511A2 Agents, uses and methods |
| 04/07/2011 | WO2011038689A1 Novel human cytokine vstm1-v2 and use thereof |
| 04/07/2011 | WO2011038662A1 Compounds as trpv1 blockers, pharmaceutical compositions and medical uses thereof |
| 04/07/2011 | US20110083201 Compositions for and methods of grazyme b inhibition |
| 04/07/2011 | US20110082206 Heteroatom containing substituted fatty acids |
| 04/07/2011 | US20110082190 Nucleic Acids Encoding Anti-IL-12 Antibody |
| 04/07/2011 | US20110082186 Compositions for inhibiting gene expression and uses thereof |
| 04/07/2011 | US20110082178 Methods of treating autoimmune and inflammatory diseases and disorders |
| 04/07/2011 | US20110082159 METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |
| 04/07/2011 | US20110082158 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same |
| 04/07/2011 | US20110082149 Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation |
| 04/07/2011 | US20110082146 Compositions and methods for inhibition of the jak pathway |
| 04/07/2011 | US20110082145 Olopatadine compositions and uses thereof |
| 04/07/2011 | US20110082142 Selective kinase inhibitors |
| 04/07/2011 | US20110082139 Substituted 8-[6-amino-3-pyridyl]xanthines |
| 04/07/2011 | US20110082126 Method for treating inflammatory conditions |
| 04/07/2011 | US20110082116 Novel compounds as cannabinoid receptor ligands |
| 04/07/2011 | US20110082113 Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity |
| 04/07/2011 | US20110082106 Methods of activating nkt cells |
| 04/07/2011 | US20110082103 Anoectochilus SPP. polysaccharide extracts for stimulating growth of advantageous bacteria, stimuating release of granulocyte colony-Stimulating factor, modulating T helper cell type I, and/or modulating T helper cell type II and uses of the same |
| 04/07/2011 | US20110082096 Gene and pathway and their use in methods and compositions for predicting onset or progression of autoimmune and/or autoinflammatory diseases |